Related Funds
Fund Name | Location |
Asia Pacific Ventures | California, Redwood City, United States |
Bay Area Equity Fund | California, San Francisco, United States |
Cenova Capital | - |
Chancery Software | British Columbia, Burnaby, Canada |
Coral Capital | Chiyoda, Japan |
Emerald Private Equity Fund | - |
Farallon Research | California, San Jose, United States |
Genesis Park | Houston, Texas, United States |
Guangzhou Derun Touzi | China, Guangdong, Guangzhou |
Haerbin Dongfang Huifu Chuangtou | China, Harbin, Heilongjiang |
Histtone Capital | China, Shanghai |
Hy Solution | - |
Juxtapose | New York, New York, United States |
MarsBio | California, Los Angeles, United States |
Merchant Bank | Burlington, United States, Vermont |
MPGI | England, London, United Kingdom |
Pipeline Angels | New York, New York, United States |
Samator | - |
Saturn Ventures | Nigeria, Port Harcourt, Rivers |
Yihua Enterprise (Group) | China, Guangdong, Shantou |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
CrossPoint Therapeutics | $1M | 01 Apr 2024 | Hwaseodong, Kyonggi-do, South Korea | ||
DAIM Research | $1M | 16 Mar 2022 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
Stoic Entertainment | $2M | 31 Dec 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Lillycover Co., Ltd. | $4M | 23 Aug 2021 | South Korea, Gyeonggi-do, South Korea | ||
IPactory | 31 May 2021 | Seocho, Seoul-t'ukpyolsi, South Korea | |||
Linewalks | $4M | 10 Nov 2020 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
Jongdal Lab | 01 Sep 2020 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
Glorang | 01 May 2019 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | |||
Tecoplus | $435K | 21 Dec 2018 | Seongnam, Kyonggi-do, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
CrossPoint Therapeutics | $1M | 01 Apr 2024 | Hwaseodong, Kyonggi-do, South Korea | ||
DAIM Research | $1M | 16 Mar 2022 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
Stoic Entertainment | $2M | 31 Dec 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Lillycover Co., Ltd. | $4M | 23 Aug 2021 | South Korea, Gyeonggi-do, South Korea | ||
IPactory | 31 May 2021 | Seocho, Seoul-t'ukpyolsi, South Korea | |||
Linewalks | $4M | 10 Nov 2020 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
Jongdal Lab | 01 Sep 2020 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
Glorang | 01 May 2019 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | |||
Tecoplus | $435K | 21 Dec 2018 | Seongnam, Kyonggi-do, South Korea |